Dec 9 (Reuters) - Sobi North America :
* SOBI RECEIVES APPROVAL FROM HEALTH CANADA FOR EMPAVELI™ (PEGCETACOPLAN) FOR THE TREATMENT OF CERTAIN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Source text for Eikon: Further company coverage:
Dec 9 (Reuters) - Sobi North America :
* SOBI RECEIVES APPROVAL FROM HEALTH CANADA FOR EMPAVELI™ (PEGCETACOPLAN) FOR THE TREATMENT OF CERTAIN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Source text for Eikon: Further company coverage: